S. 4378 · 117th Congress
Hatch-Waxman Improvement Act of 2022
- Stage
- In committee
- Sponsor
- Roger Marshall
- Introduced
- 2022-06-13
- Latest action
- 2022-06-13 · Introduced in Senate
Summary
Hatch-Waxman Improvement Act of 2022
This bill extends through FY2026 provisions that establish a period of market exclusivity for certain new drugs with single enantiomers (i.e., one of a pair of molecules that are mirror images of one another).